Progress of biomacromolecule drug nanodelivery systems in the treatment of rare diseases
Rare diseases still lack effective treatments,and the development of drugs for rare diseases(known as orphan drugs)is an urgent medical problem.As natural active ingredients in living organisms,some biomacromolecule drugs have good biocompatibility,low immunogenicity,and high targeting.They have become one of the most promising fields in drug research and development in the 21st century.However,there are still many obstacles in terms of in vivo delivery.In view of the unique advantages of nanocarriers prepared from polymers,lipids,organic biomimetic and inorganic materials in drug delivery,researchers are committed to building an efficient delivery system with versatility and synergy to solve the bottleneck issues in treating rare diseases with biomacromolecule drugs.Therefore,this article reviews the research progress of nanocarrier delivering proteins,peptides and nucleic acids in the field of rare disease treatment in the past ten years,which provides ideas for researches on biomacromolecule drug nanosystems in the field of treatment of rare diseases.
NETL
NSTL
万方数据
